-
Xavier Pi-Sunyer, the Columbia University obesity specialist who ran Sanofi's trials, sees the drug being used mostly for morbidly obese patients, not to help anyone fit into a swimsuit.
FORBES: French drug giant Sanofi prepares for fat city.
-
Medicare recently put forward a position statement saying that it would pay for gastric bypass in some obese patients.
FORBES: Magazine Article
-
He said it was unhelpful for doctors to be biased against obese patients.
BBC: NEWS | Health | Fat equals lazy, say doctors
-
Another strategy involves using less energy (100 kV instead of the standard 120 kV), which is effective but useful only for patients who are not obese.
CNN: Heart test can pack radioactive wallop
-
Obese patients create more physical work for a surgeon during any type of procedure.
WSJ: Book Excerpt: Confessions of a Surgeon
-
While obesity is a major risk factor for heart disease as well as other diseases like diabetes and even cancer, obese patients seem to have a survival benefit in certain situations.
FORBES: The 'Obesity Paradox' -- Is It Healthy To Be Overweight?
-
"People often wonder if obese patients have a worse outcome because they are more inherently at risk for complications, and we did not find that, " he says.
CNN: Obese may be less likely to survive pancreatic cancer
-
The safety and efficacy of Belviq were evaluated in three randomized, placebo-controlled trials that included nearly 8, 000 obese and overweight patients, with and without type 2 diabetes, treated for 52 to 104 weeks.
FORBES: Arena Obesity Drug Approval Looks Like Best-Case Scenario
-
The findings raise the alarm that diabetes isn't just a disease of the overweight or obese, says Carnethon, and that physicians should be looking for signs even among their leaner patients, particularly those who are elderly.
CNN: Obesity paradox: Why being thin with diabetes is dangerous
-
Patients who are obese or obese and diabetic appear to be at an increased risk for cancer, he says.
FORBES: Magazine Article